Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Royal Prima TbkISX:PRIM -1.01%74 OCF Margin % is 6.88% as of Mar. 2026, which is 51% below its 10-year median of 14.10. GuruFocus rates ISX:PRIM with a GF Score™ of 74/100 and a GF Value™ of Rp81.60 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 669 Healthcare Providers & Services companies, PT Royal Prima Tbk ranks worse than 63.83% on this metric.
The historical rank and industry rank for PT Royal Prima Tbk's OCF Margin % or its related term are showing as below:
ISX:PRIM'
s OCF Margin % Range Over the Past 10 Years
Min: -38.42 Med: 14.1 Max: 38.88
Current: 4.27
During the past 12 years, the highest OCF Margin % of PT Royal Prima Tbk was 38.88%. The lowest was -38.42%. And the median was 14.10%.
ISX:PRIM's OCF Margin % is ranked worse than 63.83% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 8.37
vs ISX:PRIM: 4.27
PT Royal Prima Tbk OCF Margin % Related Terms
PT Royal Prima Tbk OCF Margin % Historical Data
* Premium members only.
The historical data trend for PT Royal Prima Tbk's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:PRIM vs HCA, THC, DVA: OCF Margin % Comparison
For the Medical Care Facilities subindustry, PT Royal Prima Tbk's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Royal Prima Tbk OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Royal Prima Tbk's OCF Margin % distribution charts can be found below:
* The bar in red indicates where PT Royal Prima Tbk's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Royal Prima Tbk (ISX:PRIM) has a OCF Margin % of 6.88% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PT Royal Prima Tbk and its competitors. This is 51% below median its historical median of 14.10. According to the industry distribution chart, PT Royal Prima Tbk ranks #427 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 63.8%.
Is PT Royal Prima Tbk's OCF Margin % too high?
PT Royal Prima Tbk's current OCF Margin % of 6.88% is 51% below median its 10-year median of 14.10. The Healthcare Providers & Services industry median OCF Margin % is 8.37. PT Royal Prima Tbk's value of 6.88% is 17.8% below this industry median. Based on the distribution chart, PT Royal Prima Tbk ranks #427 out of 669 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Royal Prima Tbk has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Royal Prima Tbk's OCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Royal Prima Tbk ranks #427 out of 669 companies for OCF Margin %. This places PT Royal Prima Tbk in the lower half of its industry. The industry median OCF Margin % is 8.37. PT Royal Prima Tbk's value of 6.88% is 17.8% below this benchmark. While the company's 10-year median is 14.10 vs. the industry median of 8.37, PT Royal Prima Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.37, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Royal Prima Tbk's current OCF Margin % of 6.88% is 17.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PT Royal Prima Tbk and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Royal Prima Tbk's current OCF Margin % is 6.88%, which is 51% below median its own 10-year median of 14.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Royal Prima Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Royal Prima Tbk (ISX:PRIM) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp81.60, compared to a current price of Rp98.00 — trading 20.1% above its estimated fair value. The current OCF Margin % is 6.88%, which is 51% below median its 10-year median of 14.10 and 17.8% below the Healthcare Providers & Services industry median of 8.37. PT Royal Prima Tbk's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For PT Royal Prima Tbk (ISX:PRIM), the current OCF Margin % is 6.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Royal Prima Tbk (ISX:PRIM) Overvalued in 2026?
Based on GuruFocus' analysis, PT Royal Prima Tbk stock appears to be overvalued.
The current stock price of Rp98.00 is trading 20.1% above its estimated GF Value™ of Rp81.60.
GuruFocus considers PT Royal Prima Tbk to be Modestly Overvalued.
Key valuation signals for ISX:PRIM:
OCF Margin %: 6.88% (51% below median its 10-year median of 14.10)
GF Value™: Rp81.60 vs. price of Rp98.00 (20.1% above fair value)
Industry Position: 17.8% below the Healthcare Providers & Services median (#427 of 669)
No single metric tells the full story. See the ISX:PRIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Royal Prima Tbk is engaged in health services which consist of the provision of hospital services, polyclinics, hall treatment, maternity hospital, and specialist hospital. It has three geographic segments: RSU Royal Prima, RS Royal Prima Jambi, and Rumah Sakit Marelan. The company generates the majority of its revenue from RSU Royal Prima segment. The company generates revenue from Drugs and medical supplies, doctors' and nurses' fees, Hospital facilities, Room services, and Others.
74GF Score
Get the complete analysis for ISX:PRIM
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRIM has been successfully added to your 
